David A. Siegel Abiomed Inc Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$242.49 - $301.46 $5.63 Million - $6.99 Million	-23,200 Reduced 17.22%	111,499 $27.4 Million
Q2 2022 Aug 15, 2022	BUY	$224.73 - $338.64 $4.83 Million - $7.28 Million	21,500 Added 18.99%	134,699 $33.3 Million
Q1 2022 May 16, 2022	SELL	$277.25 - $366.29 $7.57 Million - $10 Million	-27,300 Reduced 19.43%	113,199 $37.5 Million
Q4 2021 Feb 14, 2022	BUY	$300.63 - $371.35 $6.49 Million - $8.02 Million	21,600 Added 18.17%	140,499 $50.5 Million
Q3 2021 Nov 15, 2021	BUY	$310.19 - $376.2 $4.16 Million - $5.04 Million	13,400 Added 12.7%	118,899 $38.7 Million
Q2 2021 Aug 16, 2021	BUY	$262.71 - $351.17 $19.1 Million - $25.5 Million	72,600 Added 220.68%	105,499 $32.9 Million
Q1 2021 May 17, 2021	BUY	$285.92 - $355.13 $8.21 Million - $10.2 Million	28,699 Added 683.31%	32,899 $10.5 Million
Q4 2020 Feb 16, 2021	SELL	$251.88 - $324.2 $1.36 Million - $1.75 Million	-5,399 Reduced 56.25%	4,200 $1.36 Million
Q3 2020 Nov 16, 2020	SELL	$255.22 - $317.0 $1.94 Million - $2.41 Million	-7,601 Reduced 44.19%	9,599 $2.66 Million
Q2 2020 Aug 14, 2020	BUY	$141.4 - $257.09 $886,436 - $1.61 Million	6,269 Added 57.35%	17,200 $4.16 Million
Q1 2020 May 15, 2020	SELL	$130.51 - $196.01 $10 Million - $15 Million	-76,599 Reduced 87.51%	10,931 $1.59 Million
Q4 2019 Feb 14, 2020	SELL	$159.31 - $223.54 $3.28 Million - $4.6 Million	-20,600 Reduced 19.05%	87,530 $14.9 Million
Q3 2019 Nov 14, 2019	SELL	$175.89 - $279.23 $39.9 Million - $63.4 Million	-227,100 Reduced 67.74%	108,130 $19.2 Million
Q2 2019 Aug 14, 2019	BUY	$250.96 - $284.94 $46 Million - $52.3 Million	183,400 Added 120.79%	335,230 $87.3 Million
Q1 2019 May 15, 2019	SELL	$276.39 - $362.25 $5.33 Million - $6.99 Million	-19,300 Reduced 11.28%	151,830 $43.4 Million
Q4 2018 Feb 14, 2019	SELL	$281.08 - $444.25 $64.5 Million - $102 Million	-229,301 Reduced 57.26%	171,130 $55.6 Million
Q3 2018 Nov 14, 2018	SELL	$354.53 - $449.75 $74.8 Million - $94.9 Million	-211,100 Reduced 34.52%	400,431 $180 Million
Q2 2018 Aug 14, 2018	BUY	$278.07 - $446.21 $161 Million - $259 Million	579,601 Added 1815.22%	611,531 $250 Million
Q1 2018 May 15, 2018	BUY	$192.49 - $295.85 $3.95 Million - $6.06 Million	20,500 Added 179.35%	31,930 $9.29 Million
Q4 2017 Feb 14, 2018	BUY	$168.78 - $199.74 $135,024 - $159,792	800 Added 7.53%	11,430 $2.14 Million
Q3 2017 Nov 14, 2017	BUY	$145.39 - $168.6 $1.55 Million - $1.79 Million	10,630	10,630 $1.79 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account